Gordon Ho


Whether it’s helping an entrepreneur navigate growth and bet-the-company decisions, or an investor evaluate its next venture, I am committed to supporting innovation.

Gordon focuses on corporate and securities law. He acts as outside corporate counsel for growth-stage companies, helping management teams establish and maintain a corporate and governance structure that will enable rapid growth throughout the life cycle of the business. Gordon counsels both private and publicly traded companies on a full range of transactions and matters, including equity and debt financings, IPOs and other securities offerings, strategic corporate relationships and joint ventures and mergers and acquisitions. He advises companies and their boards of directors on a wide range of securities, financial reporting and disclosure issues, SEC and exchange reporting and compliance, and corporate governance. Gordon also represents a diverse set of investors in connection with their financial and strategic investments in innovative technology and life sciences companies. Gordon also assists management and investors to facilitate secondary sales and liquidity opportunities. Gordon counsels companies in a wide range of industries, including software, life sciences and healthcare, energy innovation, fintech, mobile and digital media.

Download full bio 


  • Revance Therapeutics Closes $300 Million Note Purchase Agreement 

  • Lively Closes $80 Million Series C Financing 

  • AiFi Closes $65 Million Series B Financing 

  • Diamond Age Closes $50 Million Series A Financing 

  • Raydiant Closes $30 Million Series B Financing 

  • View all


  • University of San Francisco School of Law
    JD, 1997

  • University of California, Davis
    BS, Managerial Economics

Admissions & Credentials



  • American Bar Association

  • Asia America MultiTechnology Association

Cooley GO

Start and build your business with our one-stop spot for tips, documents and insights.

Let's Go!